Kaya17

KAYA17 Technology

Today, a majority of diagnostic testing occurs in centralized labs. Samples are collected in physicians’ clinics or other testing locations, and then shipped to remote centralized labs. Typically, results are only available a few days after the test is performed. This delay prevents patients from receiving timely, often life-saving, therapies.

Point of Care Testing (POCT) represents a new, transformative trend in the medical industry – the complete diagnostic tests (sample collection and analysis) is now in the physician’s clinic or testing locations. Using innovations in molecular biology and a break-through in electronic imaging, we are making diagnostic tests accurate and rapidly available on the spot. This allows for quicker diagnosis and treatment thereby lowering costs to the patient.

Sample to Result in 15 Minutes

For efficient and accurate COVID-19 diagnosis, clinicians need a portable or an on-site diagnostic test for real-time management of patients in minimal time. KAYA17’s complete rapid on-site COVID testing solution offers a complete solution to testing patients individually or in large groups very fast and accurately. The system consists of Kaya’s Assay and extraction kit, reader, software, patient ID system, and patient portal app.

KAYA17’s rapid solution is NOT a strip test that is based on color change indicator.

It uses a high sensitivity reader which results in the high performance assay to make the test yield very low false negatives. Using the patient portal, patient information and results can be exchanged much faster and safely even as patients wait in a socially distanced fashion.

The KAYA17 Workflow

KAYA17’s Patient ID Software

KAYA17 has designed a patient registration software that gathers the patient information and generates a unique patient ID QR code that gets pasted on the sample tube of the patient and the sample cartridge used to process the patient sample. The software can also receive all this information from a QR code presented by a patient portal app.

KAYA17 COVID Assay Kit

KAYA17’s test is a complete immunoassay test kit. It comes as a package of 20 tests with 2 controls. The test kit has all the necessary items (transfer pipettes, wash buffer, read buffers, and cartridges). Its proprietary reagents are fine-tuned for high sensitivity and high specificity. The kit is designed to operate with the Kaya17 Vega-200 reader to achieve very low Limit of Detection (LOD).

KAYA17’s Cartridge System

To make the test highly accurate and convenient for sample processing, KAYA17 has designed a proprietary VFC cartridge on which the COVID19 assay ( i.e. the test) is performed. To read the results, the cartridge is inserted into an electronic reader. The cartridges are one-time use items and are disposed of after each use. KAYA17 features a Patient ID QR code on the cartridge to ensure that the sample can be traced at all times and prevents sample mix-ups.

KAYA17’s VEGA-200 reader

KAYA17 has designed a high sensitivity reader to allow cartridges to be read with high accuracy and speed. The reader is integrated with our proprietary software which is embedded in a laptop supplied by us. The reader is compact, low cost, and very low power. The reader with the computer fits in a briefcase and allows for on-site testing.

KAYA17’s Results Manager

KAYA17’s software allows parallel testing with multiple readers up to 10 running tests. The results from all of the readers are transmitted to the patient ID computer where a report is generated for each patient. The reports which are stored in the computer can be transmitted to the patient or other recipients as instructed by the customer.

KAYA17’s Patient Results Portal

The most rapid and efficient way to gather patient information for a test and to disseminate test results with no-contact minimal interaction is by using an App. KAYA17 has designed a phone App that interacts with the patient ID computer to get patient data via QR code and then displays patient test results.

Medical Diagnostics Technology

A vivid demonstration of our technology is seen in how the test is conducted in the video link below. To satisfy customer preferences, KAYA17 has created a saliva test and a nasal swab test, both of which work equally well.

01. The COVID-19 Diagnosis Gap

Existing tests involve space consuming technology and take too long to deliver accurate results

02. Advantages of KAYA17

Immediacy of quantitative and qualitative results is critical to effective care and treatment

03. Needs of Today’s Healthcare System

Reduced burden on the overall healthcare system is vital to optimise patient outcomes